To access the full text documents, please follow this link: http://hdl.handle.net/10230/25793
dc.contributor.author | Martínez Aranda, Antonio |
---|---|
dc.contributor.author | Hernández, Vanessa |
dc.contributor.author | Güney, Emre, 1983- |
dc.contributor.author | Muixí, Laia |
dc.contributor.author | Foj, Ruben |
dc.contributor.author | Baixeras, Núria |
dc.contributor.author | Cuadras, Daniel |
dc.contributor.author | Moreno, Víctor |
dc.contributor.author | Urruticoechea, Ander |
dc.contributor.author | Gil, Miguel |
dc.contributor.author | Oliva Miguel, Baldomero |
dc.contributor.author | Moreno, Ferran |
dc.contributor.author | González Suárez, Eva |
dc.contributor.author | Vidal, Noemí |
dc.contributor.author | Andreu, Xavier |
dc.contributor.author | Seguí, Miquel A. |
dc.contributor.author | Ballester, Rosa |
dc.contributor.author | Castella, Eva |
dc.contributor.author | Sierra, Angels |
dc.date | 2015 |
dc.identifier.citation | Martínez-Aranda A, Hernández V, Guney E, Muixí L, Foj R, Baixeras N et al. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies. Oncotarget. 2015; 6(42): 44254-44273. DOI 10.18632/oncotarget.5471 |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | http://dx.doi.org/10.18632/oncotarget.5471 |
dc.identifier.uri | http://hdl.handle.net/10230/25793 |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Oncotarget. 2015; 6(42): 44254-44273 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | © The Authors. This is the published version of an article http://dx.doi.org/10.18632/oncotarget.5471 that appeared in the journal Oncotarget. It is published under a Creative Commons Attribution 3.0 License |
dc.rights | http://creativecommons.org/licenses/by/3.0/ |
dc.subject | Metàstasi |
dc.subject | Cervell |
dc.subject | Biomarkers |
dc.subject | Brain metastasis |
dc.subject | Breast cancer |
dc.subject | FN14 |
dc.subject | GRP94 |
dc.title | FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract | |
dc.description.abstract |